Diverse responsibilities on the biotechnology investment team, including analyzing preclinical and clinical data across all therapeutic areas, accessing market potential, and developing financial models. Opportunities to interact with company management teams (CE - Os, CMOs, CS - Os etc.), domain experts as well as attending medical conferences. Expected to provide investment insights and impact the investment process for both public and private biotechnology companies. Daily opportunity to learn directly from our senior investment professionals. Exceptional performers have potential to be promoted to Equity Research Analyst Competitive compensation with significant upside potential for high performers. Qualifications Required:Strong academic background and intellectual curiosity, PhD. or M. D. with scientific research experience. Highly motivated, confident self-starter with ability to work independently and as part of a team. Excellent communication skills (verbal and written)Preferred:Basic understanding of fundamental drug development research and preclinical / clinical data analysis. Basic understanding of financial modeling. FINRA Requirements. FINRA licenses are not required and will not be supported for this role. Work Flexibility. This role is eligible for hybrid work, with up to one day per week from home. Base Salary Ranges. Please review the job posting for the location of this specific opportunity.$130,000.00-$180,000.00 for the location of: Maryland, Colorado, Washington and remote workers$130,000.00-$180,000.00 for the location of: Washington, D.C.$130,000.00-$180,000.00 for the location of: New York, California. Placement within the range provided above is based on the individual’s relevant experience and skills for the role. Base salary is only one component of our total compensation package. Employees may be eligible for a discretionary bonus, which is determined upon company and individual performance.